{"transactions":[{"id":768626,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":32480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"date","element":"transactionDate","label":"F6","text":"The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":32480,"derivative":{"underlying":"Common Stock","underlying_shares":32480},"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":768625,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":39760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the options granted on May 20, 2026 was as follows: 13,254 shares will vest on February 26, 2027; 13,253 shares will vest on February 26, 2028; 13,253 shares will vest on February 26, 2029."}],"balance_after":39760,"derivative":{"exercise_price":1.73,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":39760},"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":768624,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":17400,"derivative":{"underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":768623,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":4688,"price":1.23,"value":5766.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":42854,"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":768622,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":8700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":47542,"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":775627,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-05-18T20:07:30.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":4771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4771},"source":{"system":"sec-edgar","filing":"0001259780-26-000005","document":"wk-form4_1779134848.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000005/wk-form4_1779134848.xml","form_type":"4"}},{"id":775626,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-18T20:07:30.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2571,"price":1.3,"value":3342.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":38842,"source":{"system":"sec-edgar","filing":"0001259780-26-000005","document":"wk-form4_1779134848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000005/wk-form4_1779134848.xml","form_type":"4"}},{"id":775625,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-18T20:07:30.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":4771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":41413,"source":{"system":"sec-edgar","filing":"0001259780-26-000005","document":"wk-form4_1779134848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000005/wk-form4_1779134848.xml","form_type":"4"}},{"id":859340,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-03-05T21:54:10.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":25520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":25520,"derivative":{"underlying":"Common Stock","underlying_shares":25520},"source":{"system":"sec-edgar","filing":"0001259780-26-000004","document":"wk-form4_1772747645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000004/wk-form4_1772747645.xml","form_type":"4"}},{"id":859339,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2026-03-05T21:54:10.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":31240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 31,240 options granted on March 4, 2026 was as follows: 10,414 shares will vest on February 26, 2027; 10,413 shares will vest on February 26, 2028; 10,413 shares will vest on February 26, 2029."}],"balance_after":31240,"derivative":{"exercise_price":1.73,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":31240},"source":{"system":"sec-edgar","filing":"0001259780-26-000004","document":"wk-form4_1772747645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000004/wk-form4_1772747645.xml","form_type":"4"}},{"id":878023,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":10634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":21266,"derivative":{"underlying":"Common Stock","underlying_shares":10634},"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878022,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":5009,"derivative":{"underlying":"Common Stock","underlying_shares":5010},"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878021,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":6294,"price":1.79,"value":11266.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein."}],"balance_after":36642,"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878020,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":10634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":42936,"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878019,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2965,"price":1.79,"value":5307.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":32302,"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878018,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":35267,"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":1139362,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2025-05-21T20:57:42.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":31950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting schedule for the 31,950 options is as follows: 15,975 shares will vest on May 20, 2027 and 15,975 shares will vest on May 20, 2028."}],"balance_after":31950,"derivative":{"exercise_price":2.13,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":31950},"source":{"system":"sec-edgar","filing":"0001055726-25-000035","document":"wk-form4_1747861055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000035/wk-form4_1747861055.xml","form_type":"4"}},{"id":1139361,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:57:42.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units is as follows: 8,700 shares will vest on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units is as follows: 8,700 shares will vest on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units is as follows: 8,700 shares will vest on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":26100,"derivative":{"underlying":"Common Stock","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001055726-25-000035","document":"wk-form4_1747861055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000035/wk-form4_1747861055.xml","form_type":"4"}},{"id":1145999,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-05-16T20:08:24.000Z","date":"2025-05-15","kind":"exercise","planned":false,"acquired":false,"shares":4771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":4771,"derivative":{"underlying":"Common Stock","underlying_shares":4771},"source":{"system":"sec-edgar","filing":"0001055726-25-000029","document":"wk-form4_1747426095.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000029/wk-form4_1747426095.xml","form_type":"4"}},{"id":1145998,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-05-16T20:08:24.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2566,"price":1.95,"value":5003.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":30257,"source":{"system":"sec-edgar","filing":"0001055726-25-000029","document":"wk-form4_1747426095.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000029/wk-form4_1747426095.xml","form_type":"4"}},{"id":1145997,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-05-16T20:08:24.000Z","date":"2025-05-15","kind":"exercise","planned":false,"acquired":true,"shares":4771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":32823,"source":{"system":"sec-edgar","filing":"0001055726-25-000029","document":"wk-form4_1747426095.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000029/wk-form4_1747426095.xml","form_type":"4"}},{"id":1239109,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:05:29.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":31900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 is as follows: 10,634 shares will vest on February 26, 2026; 10,633 shares will vest on February 26, 2027; and 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 is as follows: 10,634 shares will vest on February 26, 2026; 10,633 shares will vest on February 26, 2027; and 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 is as follows: 10,634 shares will vest on February 26, 2026; 10,633 shares will vest on February 26, 2027; and 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":31900,"derivative":{"underlying":"Common Stock","underlying_shares":31900},"source":{"system":"sec-edgar","filing":"0001055726-25-000002","document":"wk-form4_1740783922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000002/wk-form4_1740783922.xml","form_type":"4"}},{"id":1239108,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2025-02-28T23:05:29.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":39050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting schedule for the 39,050 options is as follows: 19,525 shares vested on February 27, 2025 and 19,525 shares will vest on February 26, 2026."}],"balance_after":39050,"derivative":{"exercise_price":1.94,"exercise_date":"2025-02-27","expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":39050},"source":{"system":"sec-edgar","filing":"0001055726-25-000002","document":"wk-form4_1740783922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000002/wk-form4_1740783922.xml","form_type":"4"}},{"id":1239107,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:05:29.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":10019,"derivative":{"underlying":"Common Stock","underlying_shares":5010},"source":{"system":"sec-edgar","filing":"0001055726-25-000002","document":"wk-form4_1740783922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000002/wk-form4_1740783922.xml","form_type":"4"}},{"id":1239106,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:05:29.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 11,991 restricted stock units granted on February 26, 2022 was as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 11,991 restricted stock units granted on February 26, 2022 was as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 11,991 restricted stock units granted on February 26, 2022 was as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3997},"source":{"system":"sec-edgar","filing":"0001055726-25-000002","document":"wk-form4_1740783922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000002/wk-form4_1740783922.xml","form_type":"4"}},{"id":1239105,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-28T23:05:29.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2960,"price":1.98,"value":5860.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein."}],"balance_after":28052,"source":{"system":"sec-edgar","filing":"0001055726-25-000002","document":"wk-form4_1740783922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000002/wk-form4_1740783922.xml","form_type":"4"}},{"id":1239104,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-28T23:05:29.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":31012,"source":{"system":"sec-edgar","filing":"0001055726-25-000002","document":"wk-form4_1740783922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000002/wk-form4_1740783922.xml","form_type":"4"}},{"id":1239103,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-28T23:05:29.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2362,"price":1.98,"value":4676.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":26002,"source":{"system":"sec-edgar","filing":"0001055726-25-000002","document":"wk-form4_1740783922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000002/wk-form4_1740783922.xml","form_type":"4"}},{"id":1239102,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-28T23:05:29.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":3997,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 11,991 restricted stock units granted on February 26, 2022 was as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":28364,"source":{"system":"sec-edgar","filing":"0001055726-25-000002","document":"wk-form4_1740783922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000002/wk-form4_1740783922.xml","form_type":"4"}},{"id":1514769,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-05-16T21:10:00.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":false,"shares":4771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares will vest on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares will vest on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares will vest on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":9542,"derivative":{"underlying":"Common Stock","underlying_shares":4771},"source":{"system":"sec-edgar","filing":"0001055726-24-000031","document":"wk-form4_1715893784.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000031/wk-form4_1715893784.xml","form_type":"4"}},{"id":1514768,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-16T21:10:00.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2562,"price":13.07,"value":33485.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":24367,"source":{"system":"sec-edgar","filing":"0001055726-24-000031","document":"wk-form4_1715893784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000031/wk-form4_1715893784.xml","form_type":"4"}},{"id":1514767,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-16T21:10:00.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":true,"shares":4771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares will vest on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":26929,"source":{"system":"sec-edgar","filing":"0001055726-24-000031","document":"wk-form4_1715893784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000031/wk-form4_1715893784.xml","form_type":"4"}},{"id":1613094,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:06:20.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":15029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":15029,"derivative":{"underlying":"Common Stock","underlying_shares":15029},"source":{"system":"sec-edgar","filing":"0001055726-24-000003","document":"wk-form4_1709157959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000003/wk-form4_1709157959.xml","form_type":"4"}},{"id":1613093,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2024-02-28T22:06:20.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting schedule for the 18,750 options is as follows: 4,688 shares vested on February 28, 2024; 4,688 shares will vest on February 28, 2025; 4,687 shares will vest on February 28, 2026; and 4,687 shares will vest on February 28, 2027."}],"balance_after":18750,"derivative":{"exercise_price":8.46,"exercise_date":"2024-02-28","expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001055726-24-000003","document":"wk-form4_1709157959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000003/wk-form4_1709157959.xml","form_type":"4"}},{"id":1613092,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:06:20.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 11,991 restricted stock units is as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 11,991 restricted stock units is as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 11,991 restricted stock units is as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":3997,"derivative":{"underlying":"Common Stock","underlying_shares":3997},"source":{"system":"sec-edgar","filing":"0001055726-24-000003","document":"wk-form4_1709157959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000003/wk-form4_1709157959.xml","form_type":"4"}},{"id":1613091,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:06:20.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":1878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1878},"source":{"system":"sec-edgar","filing":"0001055726-24-000003","document":"wk-form4_1709157959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000003/wk-form4_1709157959.xml","form_type":"4"}},{"id":1613090,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-28T22:06:20.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2358,"price":8.16,"value":19241.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (4) herein."}],"balance_after":22158,"source":{"system":"sec-edgar","filing":"0001055726-24-000003","document":"wk-form4_1709157959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000003/wk-form4_1709157959.xml","form_type":"4"}},{"id":1613089,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-28T22:06:20.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":3997,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 11,991 restricted stock units is as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":24516,"source":{"system":"sec-edgar","filing":"0001055726-24-000003","document":"wk-form4_1709157959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000003/wk-form4_1709157959.xml","form_type":"4"}},{"id":1613088,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-28T22:06:20.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1108,"price":8.16,"value":9041.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":20519,"source":{"system":"sec-edgar","filing":"0001055726-24-000003","document":"wk-form4_1709157959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000003/wk-form4_1709157959.xml","form_type":"4"}},{"id":1613087,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-28T22:06:20.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":1878,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":21627,"source":{"system":"sec-edgar","filing":"0001055726-24-000003","document":"wk-form4_1709157959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000003/wk-form4_1709157959.xml","form_type":"4"}},{"id":1889803,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-05-17T20:10:17.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":171756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made under the 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":171756,"derivative":{"underlying":"Common Stock","underlying_shares":171756},"source":{"system":"sec-edgar","filing":"0001055726-23-000041","document":"wk-form4_1684354196.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000041/wk-form4_1684354196.xml","form_type":"4"}},{"id":1957212,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-03-13T21:06:33.000Z","date":"2023-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-23-000011","document":"wf-form4_167874156199535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000011/wf-form4_167874156199535.xml","form_type":"4"}},{"id":1957211,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-03-13T21:06:33.000Z","date":"2023-03-11","kind":"tax_withholding","acquired":false,"shares":31410,"price":1.13,"value":35493.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":236999,"source":{"system":"sec-edgar","filing":"0001055726-23-000011","document":"wf-form4_167874156199535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000011/wf-form4_167874156199535.xml","form_type":"4"}},{"id":1957210,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-03-13T21:06:33.000Z","date":"2023-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":268409,"source":{"system":"sec-edgar","filing":"0001055726-23-000011","document":"wf-form4_167874156199535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000011/wf-form4_167874156199535.xml","form_type":"4"}},{"id":1987897,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2023-02-28T22:42:00.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting schedule for the 225,000 options is as follows: 56,250 shares vested on February 27, 2023; 56,250 shares will vest on February 26, 2024; 56,250 shares will vest on February 26, 2025; and 56,250 shares will vest on February 26, 2026."}],"balance_after":225000,"derivative":{"exercise_price":1.24,"exercise_date":"2023-02-27","expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001055726-23-000005","document":"wf-form4_167762408938905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000005/wf-form4_167762408938905.xml","form_type":"4"}},{"id":1987896,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-02-28T22:42:00.000Z","date":"2023-02-26","kind":"exercise","acquired":false,"shares":47967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 143,900 restricted stock units, vesting as follows: 47,967 shares vested on February 26, 2023; 47,967 shares will vest on February 26, 2024; and 47,966 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 143,900 restricted stock units, vesting as follows: 47,967 shares vested on February 26, 2023; 47,967 shares will vest on February 26, 2024; and 47,966 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 143,900 restricted stock units, vesting as follows: 47,967 shares vested on February 26, 2023; 47,967 shares will vest on February 26, 2024; and 47,966 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":95933,"derivative":{"underlying":"Common Stock","underlying_shares":47967},"source":{"system":"sec-edgar","filing":"0001055726-23-000005","document":"wf-form4_167762408938905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000005/wf-form4_167762408938905.xml","form_type":"4"}},{"id":1987895,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-02-28T22:42:00.000Z","date":"2023-02-26","kind":"exercise","acquired":false,"shares":22544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":22544,"derivative":{"underlying":"Common Stock","underlying_shares":22544},"source":{"system":"sec-edgar","filing":"0001055726-23-000005","document":"wf-form4_167762408938905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000005/wf-form4_167762408938905.xml","form_type":"4"}},{"id":1987894,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-02-28T22:42:00.000Z","date":"2023-02-26","kind":"tax_withholding","acquired":false,"shares":28195,"price":1.28,"value":36089.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":208672,"source":{"system":"sec-edgar","filing":"0001055726-23-000005","document":"wf-form4_167762408938905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000005/wf-form4_167762408938905.xml","form_type":"4"}},{"id":1987893,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-02-28T22:42:00.000Z","date":"2023-02-26","kind":"exercise","acquired":true,"shares":47967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 143,900 restricted stock units, vesting as follows: 47,967 shares vested on February 26, 2023; 47,967 shares will vest on February 26, 2024; and 47,966 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":236867,"source":{"system":"sec-edgar","filing":"0001055726-23-000005","document":"wf-form4_167762408938905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000005/wf-form4_167762408938905.xml","form_type":"4"}},{"id":1987892,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-02-28T22:42:00.000Z","date":"2023-02-26","kind":"tax_withholding","acquired":false,"shares":12928,"price":1.28,"value":16547.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":188900,"source":{"system":"sec-edgar","filing":"0001055726-23-000005","document":"wf-form4_167762408938905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000005/wf-form4_167762408938905.xml","form_type":"4"}},{"id":1987891,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-02-28T22:42:00.000Z","date":"2023-02-26","kind":"exercise","acquired":true,"shares":22544,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":201828,"source":{"system":"sec-edgar","filing":"0001055726-23-000005","document":"wf-form4_167762408938905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000005/wf-form4_167762408938905.xml","form_type":"4"}},{"id":2336139,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-03-14T20:29:41.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":59737,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-22-000019","document":"wf-form4_164728968540484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000019/wf-form4_164728968540484.xml","form_type":"4"}},{"id":2336138,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-03-14T20:29:41.000Z","date":"2022-03-11","kind":"tax_withholding","acquired":false,"shares":31410,"price":3.22,"value":101140.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":179284,"source":{"system":"sec-edgar","filing":"0001055726-22-000019","document":"wf-form4_164728968540484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000019/wf-form4_164728968540484.xml","form_type":"4"}},{"id":2336137,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-03-14T20:29:41.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":210694,"source":{"system":"sec-edgar","filing":"0001055726-22-000019","document":"wf-form4_164728968540484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000019/wf-form4_164728968540484.xml","form_type":"4"}},{"id":2342474,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-03-09T21:08:50.000Z","date":"2022-03-08","kind":"exercise","acquired":false,"shares":21466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21466},"source":{"system":"sec-edgar","filing":"0001055726-22-000017","document":"wf-form4_164686011126212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000017/wf-form4_164686011126212.xml","form_type":"4"}},{"id":2342473,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-03-09T21:08:50.000Z","date":"2022-03-08","kind":"tax_withholding","acquired":false,"shares":11287,"price":3.26,"value":36795.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":150957,"source":{"system":"sec-edgar","filing":"0001055726-22-000017","document":"wf-form4_164686011126212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000017/wf-form4_164686011126212.xml","form_type":"4"}},{"id":2342472,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-03-09T21:08:50.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":21466,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":162244,"source":{"system":"sec-edgar","filing":"0001055726-22-000017","document":"wf-form4_164686011126212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000017/wf-form4_164686011126212.xml","form_type":"4"}},{"id":2366348,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:49:57.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":143900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 143,900 restricted stock units is as follows: 47,967 shares will vest on February 26, 2023; 47,967 shares will vest on February 26, 2024; 47,966 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 143,900 restricted stock units is as follows: 47,967 shares will vest on February 26, 2023; 47,967 shares will vest on February 26, 2024; 47,966 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 143,900 restricted stock units is as follows: 47,967 shares will vest on February 26, 2023; 47,967 shares will vest on February 26, 2024; 47,966 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 143,900 restricted stock units is as follows: 47,967 shares will vest on February 26, 2023; 47,967 shares will vest on February 26, 2024; 47,966 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":143900,"derivative":{"underlying":"Common Stock","underlying_shares":143900},"source":{"system":"sec-edgar","filing":"0001055726-22-000012","document":"wf-form4_164617858308647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000012/wf-form4_164617858308647.xml","form_type":"4"}},{"id":2366347,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2022-03-01T23:49:57.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":192800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting schedule for the 192,800 options is as follows: 48,200 shares vested on February 26, 2022; 48,200 shares will vest on February 26, 2023; 48,200 shares will vest on February 26, 2024; 48,200 shares will vest on February 26, 2025."}],"balance_after":192800,"derivative":{"exercise_price":3.22,"exercise_date":"2022-02-26","expiration_date":"2032-02-26","underlying":"Common Stock","underlying_shares":192800},"source":{"system":"sec-edgar","filing":"0001055726-22-000012","document":"wf-form4_164617858308647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000012/wf-form4_164617858308647.xml","form_type":"4"}},{"id":2366346,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:49:57.000Z","date":"2022-02-26","kind":"exercise","acquired":false,"shares":22545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":45088,"derivative":{"underlying":"Common Stock","underlying_shares":22545},"source":{"system":"sec-edgar","filing":"0001055726-22-000012","document":"wf-form4_164617858308647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000012/wf-form4_164617858308647.xml","form_type":"4"}},{"id":2366345,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-03-01T23:49:57.000Z","date":"2022-02-26","kind":"tax_withholding","acquired":false,"shares":12555,"price":3.22,"value":40427.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":140778,"source":{"system":"sec-edgar","filing":"0001055726-22-000012","document":"wf-form4_164617858308647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000012/wf-form4_164617858308647.xml","form_type":"4"}},{"id":2366344,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-03-01T23:49:57.000Z","date":"2022-02-26","kind":"exercise","acquired":true,"shares":22545,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":153333,"source":{"system":"sec-edgar","filing":"0001055726-22-000012","document":"wf-form4_164617858308647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000012/wf-form4_164617858308647.xml","form_type":"4"}},{"id":2672504,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2021-06-11T20:24:37.000Z","date":"2021-06-09","kind":"exercise","acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":2.16,"exercise_date":"2013-03-14","expiration_date":"2023-03-14","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001055726-21-000050","document":"wf-form4_162344304755381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000050/wf-form4_162344304755381.xml","form_type":"4"}},{"id":2672503,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-11T20:24:37.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":33750,"price":10.01,"value":337837.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $10.00 to $10.04, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":130788,"source":{"system":"sec-edgar","filing":"0001055726-21-000050","document":"wf-form4_162344304755381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000050/wf-form4_162344304755381.xml","form_type":"4"}},{"id":2672502,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-11T20:24:37.000Z","date":"2021-06-09","kind":"exercise","acquired":true,"shares":13750,"price":2.16,"value":29700.0,"ownership":{"direct":true},"balance_after":164538,"source":{"system":"sec-edgar","filing":"0001055726-21-000050","document":"wf-form4_162344304755381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000050/wf-form4_162344304755381.xml","form_type":"4"}},{"id":2681447,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-04T20:08:38.000Z","date":"2021-06-03","kind":"sale","acquired":false,"shares":10000,"price":8.03,"value":80300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $8.00 to $8.09, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":150788,"source":{"system":"sec-edgar","filing":"0001055726-21-000049","document":"wf-form4_162283729943316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000049/wf-form4_162283729943316.xml","form_type":"4"}},{"id":2743339,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-04-21T22:00:41.000Z","date":"2021-04-21","kind":"sale","acquired":false,"shares":10000,"price":8.52,"value":85200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $8.49 to $8.56, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":160788,"source":{"system":"sec-edgar","filing":"0001055726-21-000037","document":"wf-form4_161904242442411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000037/wf-form4_161904242442411.xml","form_type":"4"}},{"id":2792729,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2021-03-12T23:36:32.000Z","date":"2021-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":119474,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-21-000027","document":"wf-form4_161559215079850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000027/wf-form4_161559215079850.xml","form_type":"4"}},{"id":2792728,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-03-12T23:36:32.000Z","date":"2021-03-11","kind":"tax_withholding","acquired":false,"shares":31410,"price":10.57,"value":332003.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":170788,"source":{"system":"sec-edgar","filing":"0001055726-21-000027","document":"wf-form4_161559215079850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000027/wf-form4_161559215079850.xml","form_type":"4"}},{"id":2792727,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-03-12T23:36:32.000Z","date":"2021-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":202198,"source":{"system":"sec-edgar","filing":"0001055726-21-000027","document":"wf-form4_161559215079850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000027/wf-form4_161559215079850.xml","form_type":"4"}},{"id":2800855,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2021-03-10T00:02:20.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":21467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":21466,"derivative":{"underlying":"Common Stock","underlying_shares":21467},"source":{"system":"sec-edgar","filing":"0001055726-21-000019","document":"wf-form4_161533452463255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000019/wf-form4_161533452463255.xml","form_type":"4"}},{"id":2800854,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2021-03-10T00:02:20.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":27566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27566},"source":{"system":"sec-edgar","filing":"0001055726-21-000019","document":"wf-form4_161533452463255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000019/wf-form4_161533452463255.xml","form_type":"4"}},{"id":2800853,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-03-10T00:02:20.000Z","date":"2021-03-08","kind":"tax_withholding","acquired":false,"shares":11288,"price":8.91,"value":100576.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":142461,"source":{"system":"sec-edgar","filing":"0001055726-21-000019","document":"wf-form4_161533452463255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000019/wf-form4_161533452463255.xml","form_type":"4"}},{"id":2800852,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-03-10T00:02:20.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":21467,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":153749,"source":{"system":"sec-edgar","filing":"0001055726-21-000019","document":"wf-form4_161533452463255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000019/wf-form4_161533452463255.xml","form_type":"4"}},{"id":2800851,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-03-10T00:02:20.000Z","date":"2021-03-05","kind":"tax_withholding","acquired":false,"shares":14574,"price":9.19,"value":133935.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":132282,"source":{"system":"sec-edgar","filing":"0001055726-21-000019","document":"wf-form4_161533452463255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000019/wf-form4_161533452463255.xml","form_type":"4"}},{"id":2800850,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-03-10T00:02:20.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":27566,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":146856,"source":{"system":"sec-edgar","filing":"0001055726-21-000019","document":"wf-form4_161533452463255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000019/wf-form4_161533452463255.xml","form_type":"4"}},{"id":2830319,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2021-02-27T00:09:14.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":67633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":67633,"derivative":{"underlying":"Common Stock","underlying_shares":67633},"source":{"system":"sec-edgar","filing":"0001055726-21-000014","document":"wf-form4_161438452513748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000014/wf-form4_161438452513748.xml","form_type":"4"}},{"id":2830318,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2021-02-27T00:09:14.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":104833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 104,833 options is as follows: 26,208 shares vested on February 26, 2021; 26,208 shares will vest on February 26, 2022; 26,208 shares will vest on February 26, 2023; 26,209 shares will vest on February 26, 2024."}],"balance_after":104833,"derivative":{"exercise_price":11.1,"exercise_date":"2021-02-26","expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":104833},"source":{"system":"sec-edgar","filing":"0001055726-21-000014","document":"wf-form4_161438452513748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000014/wf-form4_161438452513748.xml","form_type":"4"}},{"id":2906324,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2021-01-16T00:25:41.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"shares","element":"transactionShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."}],"balance_after":0,"derivative":{"exercise_price":4.56,"exercise_date":"2011-03-11","expiration_date":"2021-03-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001055726-21-000004","document":"wf-form4_161075672601972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000004/wf-form4_161075672601972.xml","form_type":"4"}},{"id":2906323,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-16T00:25:41.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":30000,"price":10.0186,"value":300558.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $10.00 to $10.07, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":119290,"source":{"system":"sec-edgar","filing":"0001055726-21-000004","document":"wf-form4_161075672601972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000004/wf-form4_161075672601972.xml","form_type":"4"}},{"id":2906322,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-16T00:25:41.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":30000,"price":4.56,"value":136800.0,"ownership":{"direct":true},"balance_after":149290,"source":{"system":"sec-edgar","filing":"0001055726-21-000004","document":"wf-form4_161075672601972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000004/wf-form4_161075672601972.xml","form_type":"4"}},{"id":2940636,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2020-12-18T00:07:19.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"shares","element":"transactionShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."}],"balance_after":33750,"derivative":{"exercise_price":2.16,"exercise_date":"2013-03-14","expiration_date":"2023-03-14","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001055726-20-000056","document":"wf-form4_160825002177388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000056/wf-form4_160825002177388.xml","form_type":"4"}},{"id":2940635,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2020-12-18T00:07:19.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"shares","element":"transactionShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."}],"balance_after":0,"derivative":{"exercise_price":2.4,"exercise_date":"2012-02-23","expiration_date":"2022-02-23","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001055726-20-000056","document":"wf-form4_160825002177388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000056/wf-form4_160825002177388.xml","form_type":"4"}},{"id":2940634,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-12-18T00:07:19.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":20000,"price":10.6853,"value":213706.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $10.52 to $10.83, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":119290,"source":{"system":"sec-edgar","filing":"0001055726-20-000056","document":"wf-form4_160825002177388.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000056/wf-form4_160825002177388.xml","form_type":"4"}},{"id":2940633,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-12-18T00:07:19.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":11250,"price":2.16,"value":24300.0,"ownership":{"direct":true},"balance_after":139290,"source":{"system":"sec-edgar","filing":"0001055726-20-000056","document":"wf-form4_160825002177388.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000056/wf-form4_160825002177388.xml","form_type":"4"}},{"id":2940632,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-12-18T00:07:19.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":8750,"price":2.4,"value":21000.0,"ownership":{"direct":true},"balance_after":128040,"source":{"system":"sec-edgar","filing":"0001055726-20-000056","document":"wf-form4_160825002177388.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000056/wf-form4_160825002177388.xml","form_type":"4"}},{"id":3080843,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2020-07-17T23:00:26.000Z","date":"2020-07-15","kind":"exercise","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"shares","element":"transactionShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."}],"balance_after":0,"derivative":{"exercise_price":2.4,"exercise_date":"2012-02-23","expiration_date":"2022-02-23","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001055726-20-000044","document":"wf-form4_159502681136667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/wf-form4_159502681136667.xml","form_type":"4"}},{"id":3080842,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-07-17T23:00:26.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":35000,"price":24.9488,"value":873208.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $24.21 to $25.45, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":119290,"source":{"system":"sec-edgar","filing":"0001055726-20-000044","document":"wf-form4_159502681136667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/wf-form4_159502681136667.xml","form_type":"4"}},{"id":3080841,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-07-17T23:00:26.000Z","date":"2020-07-15","kind":"exercise","acquired":true,"shares":35000,"price":2.4,"value":84000.0,"ownership":{"direct":true},"balance_after":154290,"source":{"system":"sec-edgar","filing":"0001055726-20-000044","document":"wf-form4_159502681136667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/wf-form4_159502681136667.xml","form_type":"4"}},{"id":3092816,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-07-03T01:05:48.000Z","date":"2020-06-30","kind":"sale","acquired":false,"shares":35000,"price":26.5,"value":927500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $26.13 to $26.69, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":119290,"source":{"system":"sec-edgar","filing":"0001055726-20-000043","document":"wf-form4_159373831691639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/wf-form4_159373831691639.xml","form_type":"4"}},{"id":3213977,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2020-03-12T20:41:43.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":179211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares will vest on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares will vest on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares will vest on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":179211,"derivative":{"underlying":"Common Stock","underlying_shares":179211},"source":{"system":"sec-edgar","filing":"0001055726-20-000014","document":"wf-form4_158404568493227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/wf-form4_158404568493227.xml","form_type":"4"}},{"id":3213976,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2020-03-12T20:41:43.000Z","date":"2020-03-10","kind":"exercise","acquired":false,"shares":20433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares vested on March 10, 2019; 20,433 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares vested on March 10, 2019; 20,433 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares vested on March 10, 2019; 20,433 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares vested on March 10, 2019; 20,433 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20433},"source":{"system":"sec-edgar","filing":"0001055726-20-000014","document":"wf-form4_158404568493227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/wf-form4_158404568493227.xml","form_type":"4"}},{"id":3213975,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-03-12T20:41:43.000Z","date":"2020-03-10","kind":"tax_withholding","acquired":false,"shares":7066,"price":5.7,"value":40276.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":154290,"source":{"system":"sec-edgar","filing":"0001055726-20-000014","document":"wf-form4_158404568493227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/wf-form4_158404568493227.xml","form_type":"4"}},{"id":3213974,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-03-12T20:41:43.000Z","date":"2020-03-10","kind":"exercise","acquired":true,"shares":20433,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares vested on March 10, 2019; 20,433 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":161356,"source":{"system":"sec-edgar","filing":"0001055726-20-000014","document":"wf-form4_158404568493227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/wf-form4_158404568493227.xml","form_type":"4"}},{"id":3221023,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2020-03-09T20:15:17.000Z","date":"2020-03-08","kind":"exercise","acquired":false,"shares":21467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares will vest on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares will vest on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares will vest on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares will vest on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":42933,"derivative":{"underlying":"Common Stock","underlying_shares":21467},"source":{"system":"sec-edgar","filing":"0001055726-20-000006","document":"wf-form4_158378489893679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/wf-form4_158378489893679.xml","form_type":"4"}},{"id":3221022,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2020-03-09T20:15:17.000Z","date":"2020-03-05","kind":"exercise","acquired":false,"shares":27567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":27566,"derivative":{"underlying":"Common Stock","underlying_shares":27567},"source":{"system":"sec-edgar","filing":"0001055726-20-000006","document":"wf-form4_158378489893679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/wf-form4_158378489893679.xml","form_type":"4"}},{"id":3221021,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-03-09T20:15:17.000Z","date":"2020-03-08","kind":"tax_withholding","acquired":false,"shares":7424,"price":14.09,"value":104604.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":140923,"source":{"system":"sec-edgar","filing":"0001055726-20-000006","document":"wf-form4_158378489893679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/wf-form4_158378489893679.xml","form_type":"4"}},{"id":3221020,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-03-09T20:15:17.000Z","date":"2020-03-08","kind":"exercise","acquired":true,"shares":21467,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares will vest on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":148347,"source":{"system":"sec-edgar","filing":"0001055726-20-000006","document":"wf-form4_158378489893679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/wf-form4_158378489893679.xml","form_type":"4"}},{"id":3221019,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-03-09T20:15:17.000Z","date":"2020-03-05","kind":"tax_withholding","acquired":false,"shares":9817,"price":9.8,"value":96206.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":126880,"source":{"system":"sec-edgar","filing":"0001055726-20-000006","document":"wf-form4_158378489893679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/wf-form4_158378489893679.xml","form_type":"4"}},{"id":3221018,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-03-09T20:15:17.000Z","date":"2020-03-05","kind":"exercise","acquired":true,"shares":27567,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":136697,"source":{"system":"sec-edgar","filing":"0001055726-20-000006","document":"wf-form4_158378489893679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/wf-form4_158378489893679.xml","form_type":"4"}}],"next_cursor":"2020-03-09T20:15:17.000000Z,3221018"}